Quantitative Investment Management’s Pacira BioSciences PCRX Stock Holding History

Quantitative Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,508	Closed	-$691K	–	566
2020 Q3	$691K	Buy	+11,508	New	+$669K	0.06%	216
2020 Q1	–	Sell	-81,352	Closed	-$3.69M	–	754
2019 Q4	$3.69M	Buy	+81,352	New	+$3.46M	0.11%	206
2019 Q3	–	Sell	-43,840	Closed	-$1.91M	–	734
2019 Q2	$1.91M	Buy	+43,840	New	+$1.86M	0.07%	294
2016 Q2	–	Sell	-15,400	Closed	-$815K	–	880
2016 Q1	$815K	Buy	+15,400	New	+$901K	0.04%	442

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Quantitative Investment Management's PCRX Position: Q4 2020 in Review

Quantitative Investment Management sold out of Pacira BioSciences (PCRX) in Q4 2020, closing a stake of 11,508 shares — an estimated $691K sold.

Quantitative Investment Management first reported a position in PCRX in Q1 2016 and held it in 4 quarters. The position peaked at $3.69M in Q4 2019. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2020.

Quantitative Investment Management reported no remaining Pacira BioSciences position as of Q4 2020 after selling out during the quarter.
Quantitative Investment Management sold 11,508 Pacira BioSciences shares in Q4 2020, an estimated $691K.
Quantitative Investment Management first reported a position in Pacira BioSciences in Q1 2016 and held it in 4 quarters.
Quantitative Investment Management's Pacira BioSciences position peaked at $3.69M in Q4 2019.
260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2020.

Based on Quantitative Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.